查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710265

2025年粪便移植疗法全球市场报告

Fecal Transplant Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年粪便移植治疗市场规模将强劲成长。到 2029 年，这一数字将成长至 27.1 亿美元，复合年增长率为 6.0%。预测期内的增长可以归因于生技药品治疗的应用增加、慢性病患病率上升、生物农药使用增加、新药处方增加以及患有目标疾病的患者数量增加。预测期内的关键趋势包括对微生物组研究的日益关注、合成替代品的开发、临床试验的增加、递送方法的进步以及捐赠者筛检的增长。

发炎性肠道疾病)盛行率的上升预计将推动粪便移植治疗市场的成长。 IBD 是指消化道的慢性炎症，例如克隆氏症和溃疡性大肠炎。 IBD 病例的增加可归因于食用高度加工食品、不适当或频繁使用抗生素、卫生条件改善以及儿童时期减少接触传染源等因素。透过恢復健康的肠道菌群，粪便移植疗法旨在减少发炎并缓解 IBD 患者的症状，从而可能影响疾病的管理和进展。例如，加拿大非营利组织克罗恩病和结肠炎加拿大协会在 2023 年 6 月报告称，加拿大患有 IBD 的人数预计将从 2023 年的 322,600 人增长到 2035 年的 470,000 人。因此，IBD 盛行率的不断上升正在推动粪便移植治疗市场的成长。

粪便移植治疗市场的关键参与者正专注于开发创新治疗方法，例如基于锭剂的粪便微生物群移植（FMT）疗法，以提高患者的依从性并扩大可及性。基于锭剂的 FMT 疗法涉及将捐赠者粪便中的活细菌放入口服胶囊中口服，目的是补充健康的肠道细菌并促进肠道健康。例如，2023 年 4 月，美国生物技术公司 Seres Therapeutics Inc. 和瑞士医疗保健公司雀巢健康科学公司推出了 VOWST，这是一种口服胶囊治疗药物，旨在预防成人抗生素治疗后復发性困难梭状芽孢桿菌传染病(rCDI)。与涉及整个粪便移植的传统 FMT 不同，VOWST 利用来自健康人类捐赠者的活细菌孢子来恢復肠道菌丛。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球粪便移植疗法PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球粪便移植治疗市场：成长率分析
  • 全球粪便移植治疗市场表现：规模与成长，2019-2024
  • 全球粪便移植治疗市场预测：规模与成长，2024-2029 年，2034 年
  • 全球粪便移植疗法总目标市场（TAM）

第六章市场区隔

  • 全球粪便移植治疗市场（按程序、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 粪便灌肠
  • 粪便细菌疗法
  • 粪便移植
  • 人体益生菌输液
  • 粪便输血
  • 全球粪便移植治疗市场：依疾病、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 困难梭状芽孢桿菌传染病
  • 自闭症
  • 肥胖
  • 帕金森氏症（PD）
  • 糖尿病
  • 其他疾病
  • 全球粪便移植治疗市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 专科诊所
  • 其他最终用户
  • 全球粪便移植治疗市场，依粪便灌肠剂类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 保留灌肠
  • 清洗灌肠
  • 保留粪便移植
  • 居家护理套件
  • 全球粪便移植治疗市场，依粪便细菌治疗类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 悬浮细菌疗法
  • 胶囊剂型
  • 客製化细菌製剂
  • 单菌株和多菌株产品
  • 全球粪便移植治疗市场，依粪便移植类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 直接粪便移植手术
  • 粪便悬浮液移植
  • 粪便胶囊移植
  • 自动邮件处理系统
  • 全球粪便移植治疗市场、人体益生菌注射细分市场、按类型、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 单菌株益生菌输液
  • 多菌株益生菌输液
  • 益生菌和益生元混合物
  • 医疗保健专业人员输液套件
  • 全球粪便移植治疗市场，依粪便输血类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 静脉粪便输注
  • 透过胃造口管输血
  • 预包装粪便输液
  • 基于研究的粪便输血

第七章 区域和国家分析

  • 全球粪便移植治疗市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球粪便移植治疗市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 粪便移植治疗市场：竞争格局
  • 粪便移植治疗市场：公司简介
    • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • Mount Sinai Health System Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Northwestern Medicine Overview, Products and Services, Strategy and Financial Analysis
    • NYU Langone Health Overview, Products and Services, Strategy and Financial Analysis
    • Michigan Medicine Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • UCLA Health
  • Duke University Health System Inc.
  • Stanford Health Care
  • Ferring Pharmaceuticals
  • Cincinnati Children's Hospital Medical Center
  • Emory Healthcare
  • Cambridge University Hospitals NHS Foundation Trust
  • Hamilton Health Sciences Corporation
  • Brigham and Women's Faulkner Hospital Inc.
  • Rebiotix Inc.
  • Seres Therapeutics Inc.
  • UPMC Hillman Cancer Center
  • OpenBiome
  • Center for Digestive Disease
  • BiomeBank Incorporated

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年粪便移植治疗市场：提供新机会的国家
  • 2029年粪便移植治疗市场：细分领域带来新机会
  • 粪便移植治疗市场2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31844

Fecal transplant therapy, or fecal microbiota transplantation (FMT), is a medical procedure that transfers stool from a healthy donor into a recipient's gastrointestinal (GI) tract. This treatment is primarily used to combat recurrent Clostridium difficile infections and other gut-related disorders by restoring the patient's gut flora with beneficial bacteria to enhance digestion and overall health.

The key methods of fecal transplant therapy include fecal enema, fecal bacteriotherapy, stool transplantation, human probiotic infusion, and fecal transfusion. Fecal enema involves introducing healthy donor stool into a patient's colon through an enema to rebalance gut bacteria. FMT is used to treat conditions such as Clostridium difficile infection, autism, obesity, Parkinson's disease (PD), diabetes mellitus, and others, and is administered in settings such as hospitals, specialty clinics, and other healthcare facilities.

The fecal transplant therapy market research report is one of a series of new reports from The Business Research Company that provides fecal transplant therapy market statistics, including fecal transplant therapy industry global market size, regional shares, competitors with a fecal transplant therapy market share, detailed fecal transplant therapy market segments, market trends and opportunities, and any further data you may need to thrive in the fecal transplant therapy industry. This fecal transplant therapy market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The fecal transplant therapy market size has grown strongly in recent years. It will grow from $2.02 $ billion in 2024 to $2.15 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing awareness of fecal transplant procedures, high demand for advanced treatment, growing consciousness worldwide, rise in research and development investment, and the increasing prevalence of inflammatory bowel disease.

The fecal transplant therapy market size is expected to see strong growth in the next few years. It will grow to $2.71 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to the increasing adoption of biologics for the treatment, rising prevalence of chronic illnesses, increase in the use of biopesticides, growing prescriptions for novel drugs, and the increase in patients with target medical conditions. Major trends in the forecast period include increasing focus on microbiome research, development of synthetic alternatives, rise in clinical trials, advancements in delivery methods, and growth in donor screening.

The rising prevalence of inflammatory bowel disease (IBD) is expected to drive growth in the fecal transplant therapy market. IBD refers to chronic inflammation of the gastrointestinal tract, including conditions such as Crohn's disease and ulcerative colitis. The increasing number of IBD cases is attributed to factors such as the consumption of highly processed foods, inappropriate or frequent use of antibiotics, improved hygiene, and reduced exposure to infectious agents during childhood. Fecal transplant therapy aims to restore healthy gut microbiota, thereby reducing inflammation and alleviating symptoms in patients with IBD, potentially impacting disease management and progression. For example, in June 2023, Crohn's and Colitis Canada, a Canada-based non-profit organization, reported that the number of IBD patients in Canada is projected to reach 470,000 by 2035, up from an estimated 322,600 in 2023. Therefore, the increasing prevalence of IBD is fueling the growth of the fecal transplant therapy market.

Key companies in the fecal transplant therapy market are focusing on developing innovative treatments, such as pill-based fecal microbiota transplantation (FMT) therapy, to improve patient compliance and expand accessibility. Pill-based FMT therapy involves encapsulating live bacteria from donor feces into oral capsules, aiming to replenish healthy gut bacteria and enhance intestinal health. For instance, in April 2023, Seres Therapeutics Inc., a US-based biotechnology company, and Nestle Health Science S.A., a Switzerland-based healthcare company, launched VOWST, an oral capsule treatment designed to prevent recurrent clostridioides difficile infection (rCDI) in adults following antibiotic treatment. Unlike traditional FMT, which involves transferring whole stool, VOWST utilizes live bacterial spores from healthy human donors, targeting the restoration of the gut microbiome.

In January 2022, OpenBiome, a US-based nonprofit organization, partnered with the University of Minnesota. This strategic collaboration allows OpenBiome to distribute FMT preparations developed by the University of Minnesota using good manufacturing practices, ensuring continued access to fecal microbiota transplantation for patients suffering from recurrent C. difficile infections. The University of Minnesota, a US-based public research institution, focuses on studying various diseases and treatments, including fecal transplant therapy.

Major companies operating in the fecal transplant therapy market are Mayo Clinic, Mount Sinai Health System Inc., Northwestern Medicine, NYU Langone Health, Michigan Medicine, UCLA Health, Duke University Health System Inc., Stanford Health Care, Ferring Pharmaceuticals, Cincinnati Children's Hospital Medical Center, Emory Healthcare, Cambridge University Hospitals NHS Foundation Trust, Hamilton Health Sciences Corporation, Brigham and Women's Faulkner Hospital Inc., Rebiotix Inc., Seres Therapeutics Inc., UPMC Hillman Cancer Center, OpenBiome, Center for Digestive Disease, BiomeBank Incorporated, The Regents of the University of California

North America was the largest region in the fecal transplant therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fecal transplant therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the fecal transplant therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The fecal transplant therapy market includes revenues earned by entities through donor screening and selection, stool processing and preparation, and post-procedure monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fecal Transplant Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fecal transplant therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fecal transplant therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fecal transplant therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Procedure: Fecal Enema; Fecal Bacteriotherapy; Stool Transplant; Human Probiotic Infusion; Fecal Transfusion
  • 2) By Disease: Clostridium Difficile Infection; Autism; Obesity; Parkinson's Disease (PD); Diabetes Mellitus; Other Diseases
  • 3) By End-User: Hospitals; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Fecal Enema: Retention Enema; Cleansing Enema; Retention-Based Fecal Transplants; Home Administration Kits
  • 2) By Fecal Bacteriotherapy: Suspension-Based Bacteriotherapy; Capsule Formulations; Customized Bacterial Preparations; Single Strain vs. Multi-Strain Products
  • 3) By Stool Transplant: Direct Stool Transplant Procedures; Stool Suspension Transplant; Stool Capsule Transplant; Automated Stool Preparation Systems
  • 4) By Human Probiotic Infusion: Single-Strain Probiotic Infusions; Multi-Strain Probiotic Infusions; Probiotic Blends With Prebiotics; Infusion Kits for Healthcare Providers
  • 5) By Fecal Transfusion: Intravenous Fecal Transfusion; Transfusion via Gastrostomy Tube; Pre-Packaged Fecal Transfusion Solutions; Fecal Transfusion For Research Purposes
  • Companies Mentioned: Mayo Clinic; Mount Sinai Health System Inc.; Northwestern Medicine; NYU Langone Health; Michigan Medicine
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fecal Transplant Therapy Market Characteristics

3. Fecal Transplant Therapy Market Trends And Strategies

4. Fecal Transplant Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fecal Transplant Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Fecal Transplant Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Fecal Transplant Therapy Market Growth Rate Analysis
  • 5.4. Global Fecal Transplant Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Fecal Transplant Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Fecal Transplant Therapy Total Addressable Market (TAM)

6. Fecal Transplant Therapy Market Segmentation

  • 6.1. Global Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fecal Enema
  • Fecal Bacteriotherapy
  • Stool Transplant
  • Human Probiotic Infusion
  • Fecal Transfusion
  • 6.2. Global Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clostridium Difficile Infection
  • Autism
  • Obesity
  • Parkinson's Disease (PD)
  • Diabetes Mellitus
  • Other Diseases
  • 6.3. Global Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End-Users
  • 6.4. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Fecal Enema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retention Enema
  • Cleansing Enema
  • Retention-Based Fecal Transplants
  • Home Administration Kits
  • 6.5. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Fecal Bacteriotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Suspension-Based Bacteriotherapy
  • Capsule Formulations
  • Customized Bacterial Preparations
  • Single Strain vs. Multi-Strain Products
  • 6.6. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Stool Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Stool Transplant Procedures
  • Stool Suspension Transplant
  • Stool Capsule Transplant
  • Automated Stool Preparation Systems
  • 6.7. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Human Probiotic Infusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Strain Probiotic Infusions
  • Multi-Strain Probiotic Infusions
  • Probiotic Blends With Prebiotics
  • Infusion Kits for Healthcare Providers
  • 6.8. Global Fecal Transplant Therapy Market, Sub-Segmentation Of Fecal Transfusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Fecal Transfusion
  • Transfusion via Gastrostomy Tube
  • Pre-Packaged Fecal Transfusion Solutions
  • Fecal Transfusion For Research Purposes

7. Fecal Transplant Therapy Market Regional And Country Analysis

  • 7.1. Global Fecal Transplant Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Fecal Transplant Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fecal Transplant Therapy Market

  • 8.1. Asia-Pacific Fecal Transplant Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fecal Transplant Therapy Market

  • 9.1. China Fecal Transplant Therapy Market Overview
  • 9.2. China Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fecal Transplant Therapy Market

  • 10.1. India Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fecal Transplant Therapy Market

  • 11.1. Japan Fecal Transplant Therapy Market Overview
  • 11.2. Japan Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fecal Transplant Therapy Market

  • 12.1. Australia Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fecal Transplant Therapy Market

  • 13.1. Indonesia Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fecal Transplant Therapy Market

  • 14.1. South Korea Fecal Transplant Therapy Market Overview
  • 14.2. South Korea Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fecal Transplant Therapy Market

  • 15.1. Western Europe Fecal Transplant Therapy Market Overview
  • 15.2. Western Europe Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fecal Transplant Therapy Market

  • 16.1. UK Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fecal Transplant Therapy Market

  • 17.1. Germany Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fecal Transplant Therapy Market

  • 18.1. France Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fecal Transplant Therapy Market

  • 19.1. Italy Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fecal Transplant Therapy Market

  • 20.1. Spain Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fecal Transplant Therapy Market

  • 21.1. Eastern Europe Fecal Transplant Therapy Market Overview
  • 21.2. Eastern Europe Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fecal Transplant Therapy Market

  • 22.1. Russia Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fecal Transplant Therapy Market

  • 23.1. North America Fecal Transplant Therapy Market Overview
  • 23.2. North America Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fecal Transplant Therapy Market

  • 24.1. USA Fecal Transplant Therapy Market Overview
  • 24.2. USA Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fecal Transplant Therapy Market

  • 25.1. Canada Fecal Transplant Therapy Market Overview
  • 25.2. Canada Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fecal Transplant Therapy Market

  • 26.1. South America Fecal Transplant Therapy Market Overview
  • 26.2. South America Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fecal Transplant Therapy Market

  • 27.1. Brazil Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fecal Transplant Therapy Market

  • 28.1. Middle East Fecal Transplant Therapy Market Overview
  • 28.2. Middle East Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fecal Transplant Therapy Market

  • 29.1. Africa Fecal Transplant Therapy Market Overview
  • 29.2. Africa Fecal Transplant Therapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Fecal Transplant Therapy Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Fecal Transplant Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fecal Transplant Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Fecal Transplant Therapy Market Competitive Landscape
  • 30.2. Fecal Transplant Therapy Market Company Profiles
    • 30.2.1. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Mount Sinai Health System Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Northwestern Medicine Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. NYU Langone Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Michigan Medicine Overview, Products and Services, Strategy and Financial Analysis

31. Fecal Transplant Therapy Market Other Major And Innovative Companies

  • 31.1. UCLA Health
  • 31.2. Duke University Health System Inc.
  • 31.3. Stanford Health Care
  • 31.4. Ferring Pharmaceuticals
  • 31.5. Cincinnati Children's Hospital Medical Center
  • 31.6. Emory Healthcare
  • 31.7. Cambridge University Hospitals NHS Foundation Trust
  • 31.8. Hamilton Health Sciences Corporation
  • 31.9. Brigham and Women's Faulkner Hospital Inc.
  • 31.10. Rebiotix Inc.
  • 31.11. Seres Therapeutics Inc.
  • 31.12. UPMC Hillman Cancer Center
  • 31.13. OpenBiome
  • 31.14. Center for Digestive Disease
  • 31.15. BiomeBank Incorporated

32. Global Fecal Transplant Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fecal Transplant Therapy Market

34. Recent Developments In The Fecal Transplant Therapy Market

35. Fecal Transplant Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Fecal Transplant Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Fecal Transplant Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Fecal Transplant Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer